产品: Occludin 抗体
货号: DF7504
描述: Rabbit polyclonal antibody to Occludin
应用: WB IHC IF/ICC
文献验证: WB, IHC, IF/ICC
反应: Human, Mouse, Rat, Pig
预测: Pig, Bovine, Horse, Sheep, Rabbit, Dog, Chicken
蛋白号: Q16625
RRID: AB_2841004

浏览相似产品>>

   规格 价格 库存
 50ul RMB¥ 1250 现货
 100ul RMB¥ 2300 现货
 200ul RMB¥ 3000 现货

货期: 当天发货

联系销售

产品描述

来源:
Rabbit
应用:
WB 1:1000-3000, IHC 1:50-1:200, IF/ICC 1:200
*The optimal dilutions should be determined by the end user.
*Tips:

WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.

反应:
Human, Mouse, Rat, Pig
克隆:
Polyclonal
特异性:
Occludin Antibody detects endogenous levels of total Occludin.
RRID:
AB_2841004
引用格式: Affinity Biosciences Cat# DF7504, RRID:AB_2841004.
偶联:
Unconjugated.
纯化:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
别名:

展开/折叠

BLCPMG; FLJ08163; FLJ18079; FLJ77961; FLJ94056; MGC34277; Occludin; Ocln; OCLN_HUMAN; Tight junction protein occludin;

抗原和靶标

免疫原:

A synthesized peptide derived from human Occludin, corresponding to a region within the internal amino acids.

基因/基因ID:

研究领域

· Cellular Processes > Cellular community - eukaryotes > Tight junction.   (View pathway)

· Environmental Information Processing > Signaling molecules and interaction > Cell adhesion molecules (CAMs).   (View pathway)

· Human Diseases > Infectious diseases: Bacterial > Pathogenic Escherichia coli infection.

· Human Diseases > Infectious diseases: Viral > Hepatitis C.

· Organismal Systems > Immune system > Leukocyte transendothelial migration.   (View pathway)

文献引用

1). Dietary fiber alleviates alcoholic liver injury via Bacteroides acidifaciens and subsequent ammonia detoxification. Cell host & microbe, 2024 (PubMed: 38959900) [IF=20.6]

2). Gingerenone A Attenuates Ulcerative Colitis via Targeting IL-17RA to Inhibit Inflammation and Restore Intestinal Barrier Function. Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024 (PubMed: 38639442) [IF=15.1]

Application: IF/ICC    Species: Mouse    Sample:

Figure 2. GA suppressed inflammation and protected against intestinal barrier dysfunction to attenuate colitis in mice. A) Inflammatory cytokines (IL‐1β, IL‐6, IL‐17, and TNF‐α) levels in colonic tissues (n = 6). B) Inflammatory cytokines (IL‐1β, IL‐6, IL‐17, and TNF‐α) levels in serum (n = 6). C) MPO activity in colonic tissues (n = 6). D,E) NIMP‐R14 positive expression level, and representative IHC pictures of NIMP‐R14 protein (n = 6). F) Representative immunofluorescence images of ZO‐1, Occludin, and Muc‐2 in colonic tissues (n = 3). G) Serum FD4 level (n = 6) and the fluorescence intensities of ZO‐1, Occludin, and Muc‐2 (n = 3). H) Pearson correlation heatmap circos among pro‐inflammation cytokines levels, intestinal barrier function proteins, and pharmacodynamic evaluation index in different groups (n = 3). All data are expressed as mean ± S.E.M. *P < 0.05 and **P < 0.01 compared with the control group (Ctrl), #P < 0.05 and ## P < 0.01 compared with the DSS group.

3). The role of the microbiota–gut–brain axis in methamphetamine-induced neurotoxicity: Disruption of microbial composition and short-chain fatty acid metabolism. Acta Pharmaceutica Sinica B, 2024 (PubMed: 39664442) [IF=14.7]

4). Hepatic factor MANF drives hepatocytes reprogramming by detaining cytosolic CK19 in intrahepatic cholangiocarcinoma. Cell death and differentiation, 2024 (PubMed: 39972058) [IF=13.7]

5). Hepatic factor MANF drives hepatocytes reprogramming by detaining cytosolic CK19 in intrahepatic cholangiocarcinoma. Cell death and differentiation, 2024 (PubMed: 39972058) [IF=13.7]

6). Dietary palmitoleic acid reprograms gut microbiota and improves biological therapy against colitis. Gut microbes, 2023 (PubMed: 37203220) [IF=12.2]

7). Extracellular vesicles of Fusobacterium nucleatum compromise intestinal barrier through targeting RIPK1-mediated cell death pathway. Gut Microbes, 2021 (PubMed: 33769187) [IF=12.2]

Application: IHC    Species: mouse    Sample: colon

Figure 5. |FnEVs increase gut barrier leakage in experimental colitis models. (a) Representative images and ex vivo imaging with the intestine, liver, heart, spleen and kidney of mice. (b) Relative fluorescence intensity of translocated EGFP-labeled E.coli in every tissues. (c) Representative images of immunohistochemical stainings of ZO-1, claudin-1 and occludin in the colon on day 3 after colitis induction. Scale bar = 50 um.

8). Beneficial Effects of Celastrol on Immune Balance by Modulating Gut Microbiota in Experimental Ulcerative Colitis Mice. Genomics, proteomics & bioinformatics, 2022 (PubMed: 35609771) [IF=11.5]

9). Water-extracted Lonicera japonica polysaccharide attenuates allergic rhinitis by regulating NLRP3-IL-17 signaling axis. Carbohydrate Polymers, 2022 (PubMed: 36184153) [IF=10.7]

10). Vitamin K1 ameliorates lipopolysaccharide-triggered skeletal muscle damage revealed by faecal bacteria transplantation. Journal of cachexia, sarcopenia and muscle, 2024 (PubMed: 38018317) [IF=9.4]

Application: WB    Species: Mouse    Sample:

Figure 2 Faecal bacteria transplantation from S‐res mice alleviates LPS‐triggered muscle damage and intestinal barrier disruption. (A) Description of the steps of FMT experiment. (B) The score for Severity of sepsis in Sen and Res. (C) H&E staining in the GA muscle. Representative histological images on day 9 postoperatively (400× magnification). Scale bar = 100 μm. Comparison of muscle fibre diameter and CSA of muscle fibre in mice from each group. (D) Western blot analysis of MuRF‐1 and MAFbx protein levels in TA tissue in Sen and Res groups. The results were normalized to the expression of GAPDH. (E) Western blot analysis of ZO‐1 and occludin protein levels in colon tissue in Sen and Res groups. The results were normalized to the expression of GAPDH. Data are means ± SEM. P values determined through Student's t test and ordinary one‐way ANOVA. Sen versus Res: # P < 0.05, ## P < 0.01, ### P < 0.001. Sen and Res versus Ctrl: **P < 0.01, ***P < 0.001. Sen versus ABX: $ P < 0.05.

加载更多

限制条款

产品的规格、报价、验证数据请以官网为准,官网链接:www.affbiotech.com | www.affbiotech.cn(简体中文)| www.affbiotech.jp(日本語)

产品的数据信息为Affinity所有,未经授权不得收集Affinity官网数据或资料用于商业用途,对抄袭产品数据的行为我们将保留诉诸法律的权利。

产品相关数据会因产品批次、产品检测情况随时调整,如您已订购该产品,请以订购时随货说明书为准,否则请以官网内容为准,官网内容有改动时恕不另行通知。

Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时,请您在Affinity官方渠道提交售后申请。

产品仅供科学研究使用。不用于诊断和治疗。 

产品未经授权不得转售。

Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.